Eton Pharmaceuticals, Inc. (ETON) FY2026 Q2 Balance Sheet

Income StatementCash FlowBalance Sheet

Balance Sheet

As of 2026-06-30

Swipe to see the full flow
Eton Pharmaceuticals, Inc. (ETON) FY2026 Q2 Balance SheetBalance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.Current liabilities$45.12 MLiabilities$69.22 MCurrent assets$68.60 MNon-current liabilities$24.10 MAssets$115.81 MEquity$46.59 MGross equity(calculated)$145.95 MNon-current assets$47.21 MHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSCash and cash equivalentsAccounts receivable, netInventories, netPrepaid expenses and other current assetsIntangible assets, netOperating lease right-of-use assets, netProperty and equipment, netOther long-term assets, netAccounts payableAccrued Medicaid rebatesAccrued Liabilities, CurrentShort-term debt, net of debt discountLong-term debt, net of current portion and debt discount and accrued exit feesOther long-term liabilitiesOperating lease liabilities, net of current portionAdditional paid-in capitalCommon stock, $0.001 par value; 50,000,000 shares authorized; 28,289,941 and 27,047,061 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectivelyCurrent assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilitiesEquityGross equity (calculated)Accumulated deficitCurrent liabilitiesCurrent liabilities$45.12 MAccounts payableAccounts payable$14.41 MLiabilitiesLiabilities$69.22 MAccrued Medicaid rebatesAccrued Medicaid rebates$10.97 MAccrued Liabilities, CurrentAccrued Liabilities, Current$10.93 MCurrent assetsCurrent assets$68.60 MShort-term debt, net of debt discountShort-term debt, net of debt discount$8.83 MCash and cash equivalentsCash and cash equivalents$26.85 MNon-current liabilitiesNon-current liabilities$24.10 MAssetsAssets$115.81 MLong-term debt, net of current portion and debt discount and accrued exit feesLong-term debt, net$19.08 MAccounts receivable, netAccounts receivable, net$24.89 MOther long-term liabilitiesOther long-term liabilities$3.94 MEquityEquity$46.59 MOperating lease liabilities, net of current portionOperating lease liabilities, net of current portion$1.08 MInventories, netInventories, net$10.14 MGross equity (calculated)Gross equity(calculated)$145.95 MPrepaid expenses and other current assetsPrepaid expenses and other current assets$6.73 MNon-current assetsNon-current assets$47.21 MIntangible assets, netIntangible assets, net$45.68 MOperating lease right-of-use assets, netOperating lease right-of-use assets, net$1.11 MAdditional paid-in capitalAdditional paid-in capital$145.92 MProperty and equipment, netProperty and equipment, net$352.00 KOther long-term assets, netOther long-term assets, net$64.00 KCommon stock, $0.001 par value; 50,000,000 shares authorized; 28,289,941 and 27,047,061 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectivelyCommon stock$28.00 KAccumulated deficitAccumulated deficit−$99.36 M
Chart details

Eton Pharmaceuticals, Inc. (ETON) FY2026 Q2 Balance Sheet

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

Assets
115,807,000 US dollars
Current assets
68,599,000 US dollars
Non-current assets
47,208,000 US dollars
Liabilities
69,222,000 US dollars
Current liabilities
45,124,000 US dollars
Non-current liabilities
24,098,000 US dollars
Equity
46,585,000 US dollars
Cash and cash equivalents
26,845,000 US dollars
Accounts receivable, net
24,886,000 US dollars
Inventories, net
10,143,000 US dollars
Prepaid expenses and other current assets
6,725,000 US dollars
Intangible assets, net
45,678,000 US dollars
Operating lease right-of-use assets, net
1,114,000 US dollars
Property and equipment, net
352,000 US dollars
Other long-term assets, net
64,000 US dollars
Accounts payable
14,405,000 US dollars
Accrued Medicaid rebates
10,969,000 US dollars
Accrued Liabilities, Current
10,925,000 US dollars
Short-term debt, net of debt discount
8,825,000 US dollars
Long-term debt, net of current portion and debt discount and accrued exit fees
19,078,000 US dollars
Other long-term liabilities
3,937,000 US dollars
Operating lease liabilities, net of current portion
1,083,000 US dollars
Additional paid-in capital
145,919,000 US dollars
Common stock, $0.001 par value; 50,000,000 shares authorized; 28,289,941 and 27,047,061 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively
28,000 US dollars
Accumulated deficit
negative 99,362,000 US dollars
Gross equity (calculated)
145,947,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
Eton Pharmaceuticals, Inc. (ETON) FY2026 Q2 Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!